(d) Degradation of 35S-labeled wild-type human cycB1-NT (1-88) in mitotic Xenopus extract supplemented concomitantly with unlabeled WT human cycB1-NT (1-88), WT or D-box mutant sea urchin cyclin B1 NT (13-110), at indicated concentrations.